Want to join the conversation?
Biotechnology company $AMGN said the European Commission (EC) has approved the marketing authorization for Kyprolis to include use in combination with dexamethasone for adults with multiple myeloma, an incurable blood cancer, who have received at least one prior therapy.
$JNJ down 2% in pre-market trading. Earnings beat expectations, but sales disappointed. Johnson is cautious on its outlook. How it will perform in the future?
$YHOO is reporting today after market close. Nobody cares about this stock.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.